GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (WBO:QGE2) » Definitions » Accumulated other comprehensive income (loss)

Qiagen NV (WBO:QGE2) Accumulated other comprehensive income (loss) : €-390 Mil (As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Qiagen NV Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Qiagen NV's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2024 was €-390 Mil.

Qiagen NV's quarterly Accumulated other comprehensive income (loss) increased from Sep. 2023 (€-411 Mil) to Dec. 2023 (€-398 Mil) and increased from Dec. 2023 (€-398 Mil) to Mar. 2024 (€-390 Mil).

Qiagen NV's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 (€-289 Mil) to Dec. 2022 (€-381 Mil) and declined from Dec. 2022 (€-381 Mil) to Dec. 2023 (€-398 Mil).

Qiagen NV Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Qiagen NV's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qiagen NV Accumulated other comprehensive income (loss) Chart

Qiagen NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -278.66 -200.42 -289.10 -381.46 -397.82

Qiagen NV Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -370.11 -385.72 -411.05 -397.82 -390.22

Qiagen NV Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Qiagen NV Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Qiagen NV's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Qiagen NV (WBO:QGE2) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (WBO:QGE2) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
EXAS NTRA CRL MEDP RVTY RDNT DGX SHC NEOG GH TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT
Traded in Other Exchanges
QGEN:USA 1QGEN:Italy QIAd:UK 0RLT:UK QIA:Germany
Address
Hulsterweg 82, Venlo, LI, NLD, 5912 PL
Website
https://www.qiagen.com
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).

Qiagen NV (WBO:QGE2) Headlines

No Headlines